BioApplications Inc.
BioApp was established in 2011 based on POSTECH's plant biotechnology. It has achieved significant milestones, being the first to accomplish various achievements in both Korea and globally. Notably, the HERBAVAC™ CSF Green Marker vaccine, the world's inaugural plant-based classical swine fever vaccine, has been approved. BioApp aims to contribute to eliminating classical swine fever by achieving …
Profile
- Industry
- Alternative proteins, CEA & horticulture, Fishery & aquaculture, Food ingredients, Paints & coatings, Seeds & genetics, Veterinary
- Topics
- Animal & aquaculture vaccines, Livestock & poultry production/genetics, Plant-based meat, dairy & egg, Precision fermentation (proteins, dairy, egg)
- Role
- Research / RTO — “…orations with universities, research institutes, and industry partners (e.g., Amicogen, POSCO International, H…”
- Parent / group
- Spin-off from Pohang University of Science and Technology (POSTECH)
- Why it is bioeconomy
- BioApplications Inc. is a biotechnology company specializing in plant-based biopharmaceutical manufacturing platforms and the development of veterinary vaccines.
- Found via
- [Rubric] South Korea · animal-vaccines
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
News & status 6
- 2025-06 Latest status: The company's planned merger with Hanwha Plus No. 4 SPAC was cancelled in 2025. ↗ ↗ ↗
- 2026-09-07 바이오앱, 국군의학연구소와 업무협약...식물 플랫폼 활용 백신개발 < 제약·바이오 < 산업 < 기사본문 - 팜뉴스BioApps (바이오앱) is partnering with the Military Medical Research Institute to develop plant-platform-based “green vaccines” for both infectious and biologic agents, aiming to rapidly produce multistrain vaccines and support national vaccine security, with plans …
- 2026-07-28 바이오앱, 중기부 '2026 스케일업 팁스' 선정BioApps (바이오앱) has been selected as the principal entity for the 2026 Scale-Up TIPS project by the Ministry of SMEs and Startups. The company will lead a 3-year, 300 million KRW project to develop a noninvasive, topical hydrogel for canine and feline atopic …
- 2026-07-26 국립농업과학원-바이오앱, 그린바이오 미래 경쟁력 확보 위해 맞손BioApplications Inc. (바이오앱) is collaborating with the Korea National Institute of Agricultural Sciences to accelerate commercializing green bio tech. They will jointly research, share data and facilities, and leverage BioApps’ plant-based production platform …
- 2026-07-28 Development of Pet Atopic Dermatitis Treatment Begins in Earnest… BioApp Selected for Scale-up TIPS - 벤처스퀘어BioApp (BioApplications Inc.) is spearheading a government-supported R&D project under Korea’s Scale-Up TIPS to develop a plant-protein–based topical hydrogel for atopic dermatitis in dogs and cats, aiming for a two-track strategy of quasi-drug skin care …
- 2025-08-12 BioApp selected as a participating company for the "Green Vaccine-Based ASF Response Platform Development Project." - 벤처스퀘어BioApp (BioApplications Inc.) has been selected as a participating company in South Korea’s Green Vaccine Technology-Based Livestock Infectious Disease Rapid Response Platform Development Project to develop an ASF vaccine using plant-based technology, …
- 2025-05-18 바이오앱, 식물 백신 생태계 확대...에이엔폴리와 식물 유래 ECM 개발 MOUBioApplications Inc. (바이오앱) is collaborating with ENPOLY to develop and commercialize plant-derived extracellular matrix (ECM) for biotech, pharmaceuticals, and regenerative medicine, aiming to overcome limitations of animal-derived ECM and advance safer, …
Network: owners, partners, peers
Ownership & investors 1
| parent | Spin-off from Pohang University of Science and Technology |
Similar companies
Choong Ang Vaccine Laboratories Co., Ltd. · Green Cross Veterinary Products Co., Ltd. · GC Biopharma (GC녹십자) · Hualan Biological Engineering Inc. · INATA · Reber Genetics Co., Ltd. · China National Biotec Group Company Limited · Euglena Co., Ltd. - 株式会社ユーグレナ
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member